Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Q32 Bio (QTTB) EBT Margin (2018 - 2023)

Historic EBT Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 1971.62%.

  • Q32 Bio's EBT Margin rose 60911900.0% to 1971.62% in Q4 2023 from the same period last year, while for Sep 2024 it was 4318.6%, marking a year-over-year increase of 49954400.0%. This contributed to the annual value of 803.26% for FY2023, which is 8406100.0% down from last year.
  • According to the latest figures from Q4 2023, Q32 Bio's EBT Margin is 1971.62%, which was up 60911900.0% from 751.26% recorded in Q3 2023.
  • Q32 Bio's 5-year EBT Margin high stood at 11678.68% for Q1 2022, and its period low was 8834.07% during Q1 2019.
  • Over the past 5 years, Q32 Bio's median EBT Margin value was 3704.86% (recorded in 2022), while the average stood at 2663.06%.
  • Per our database at Business Quant, Q32 Bio's EBT Margin surged by 116823400bps in 2022 and then crashed by -119107100bps in 2023.
  • Quarter analysis of 5 years shows Q32 Bio's EBT Margin stood at 4292.54% in 2019, then grew by 29bps to 3039.9% in 2020, then tumbled by -38bps to 4187.41% in 2021, then increased by 2bps to 4119.58% in 2022, then surged by 148bps to 1971.62% in 2023.
  • Its EBT Margin was 1971.62% in Q4 2023, compared to 751.26% in Q3 2023 and 181.19% in Q2 2023.